IL-6R–related diseases like mycosis fungoides, castleman's disease, as well as inflammatory disorders such as rheumatoid arthritis and other cutaneous diseases are currently of interest for PDT and their treatment might be improved by further development of aptamer conjugates in the future.41,42,43. Here, IL6R is linked to glycogen storage disease VI.